Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 25.6.2024Olikla s.r.o. (OLK)2375DLatanoprost/timolol Olikla 0,05 mg/ml + 5 mg/ml očné roztokové kvapky (int opo 1x2,5 ml (fľ.LDPE))15.7.2024R
 25.6.2024Olikla s.r.o. (OLK)5448DMicafungin Olikla 100 mg prášok na infúzny koncentrát (plc ifc 1x100 mg (liek.inj.skl.))25.6.2024O
 25.6.2024Takeda Pharma A/S (TAA-2)55582Xefo 4 mg filmom obalené tablety (tbl flm 50x4 mg (blis.PVC/Al))25.6.2024O
 24.6.2024Takeda Pharmaceuticals International AG Ireland Branch (TAK-IE-1)36386Fosrenol 750 mg žuvacie tablety (tbl mnd 90(6x15)x750 mg (fľ.HDPE-multi bal.))1.7.2024R
 24.6.2024Takeda Pharmaceuticals International AG Ireland Branch (TAK-IE-1)36379Fosrenol 500 mg žuvacie tablety (tbl mnd 90(2x45)x500 mg (fľ.HDPE-multi bal.))1.7.2024R
 24.6.2024Teva B.V. (TEV-NL-4)0512EAtorvastatín/Ezetimib Teva 80 mg/10 mg (tbl flm 100(2x50)x80 mg/10 mg (blis.OPA/Al/PVC/Al-multibal.))21.6.2024O
 24.6.2024Teva B.V. (TEV-NL-4)0486EAtorvastatín/Ezetimib Teva 40 mg/10 mg (tbl flm 90x40 mg/10 mg (blis.OPA/Al/PVC/Al))24.6.2024O
 24.6.2024Teva B.V. (TEV-NL-4)91373Gabapentin-Teva 300 mg (cps dur 50x300 mg (blis.PVC/PVDC/Al))24.6.2024O
 24.6.2024Teva B.V. (TEV-NL-4)1220BSastravi 150 mg/37,5 mg/200 mg (tbl flm 100x150 mg/37,5 mg/200 mg (obal HDPE))19.8.2024Z
 24.6.2024Johnson & Johnson, s.r.o. (JHN-SK-1)49926Concerta 54 mg tablety s predĺženým uvoľňovaním (tbl plg 30x54 mg (fľ.HDPE))21.6.2024O
 24.6.2024B.Braun Melsungen AG (BME)80553Braunol (sol der 1x1000 ml (fľ.PE))24.6.2024R
 21.6.2024B.Braun Melsungen AG (BME)13907Chlorid sodný B. Braun 0,9 % infúzny roztok (sol inf 10x1000 ml (fľ.PE))21.6.2024O
 21.6.2024Viatris Healthcare Limited (VIM-1)26526Kreon 10 000 (cps end 50x150 mg (fľ.HDPE))24.6.2024R
 21.6.2024AbbVie Deutschland GmbH & Co. KG (ABV-DE)3297DRINVOQ 15 mg tablety s predĺženým uvoľňovaním (tbl plg 98 (2x49)x15 mg (blis.PVC/PE/PCTFE/Al))1.6.2024U
 21.6.2024Takeda Manufacturing Austria AG (TKM-5)97250KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x200 ml/20 g (liek.inj.skl.))21.6.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)